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ABSTRACT
Osteoarthritis (OA) is a degenerative joint disease whose exact mechanisms are
not well understood, but aging and obesity are common risk factors. To determine the
role of transforming growth factor-alpha (TGFα) in obesity-associated OA, Tgfa null and
control mice on control and high fat diets were compared. In addition, spontaneous OA
was investigated in aging C57BL/6J mice. Quantitative magnetic resonance was used to
assess body composition in the obesity model, while gait analysis, histological staining
and OARSI scoring were used to determine OA in both models. Mice on the high fat diet
developed no OA, but Tgfa null mice weighed significantly less than controls due to
decreased fat mass. Reduced liver size was also observed. Two-year-old male, but not
female, C57BL/6J mice had increased OA, although less severe than expected. This study
has identified TGFα as a potential regulator of metabolism, and provided new data on the
rate of OA in aging C57BL/6J mice.

Keywords: Aging, obesity, transforming growth factor alpha, C57BL/6J, osteoarthritis,
gait analysis, metabolism
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1.0 INTRODUCTION
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1.1

Osteoarthritis
Osteoarthritis (OA) is a painful, debilitating degenerative disease that mainly

affects articular joints (Buckwalter, Saltzman et al. 2004). OA is the most common form
of arthritis and currently over four million Canadians are afflicted with some form of OA
(Kopec, Sayre et al. 2010). OA affects articular joints such as the knees, hips and hands
causing joint space narrowing, loss of cartilage and subchondral bone changes (Hinton,
Moody et al. 2002). Individuals suffering from OA experience physical pain and
psychological distress because of the debilitating nature of the disease (Wise, Niu et al.
2010). Aging, obesity, genetic predisposition, and gender are just some of the risk factors
that have been attributed to an individuals susceptibility for developing OA (Sowers
2001). Due to the aging population, by the year 2026 almost a quarter of the North
American population will be over 65 years of age, and the incidence of musculoskeletal
diseases such as OA is only expected to rise (Needham, Bronskill et al. 2005; Kopec,
Sayre et al. 2010). The increasing prevalence of OA will create a huge financial stress on
our health care system and our economy (Kopec, Sayre et al. 2010; Tarride, Haq et al.
2012).

1.1.1

Classification
Generally OA is classified into two types, primary or secondary OA. Primary, or

idiopathic, OA was originally thought to be due to “wear and tear” of the joint, but the
direct cause is unknown (Ratcliffe, Israel et al. 1998; Buckwalter and Martin 2006). Age
is most typically considered the major risk factor for primary OA as it is seldom found in
individuals under 40, but again this type of OA is usually diagnosed without a known
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underlying cause for disease development (Ratcliffe, Israel et al. 1998; Buckwalter and
Martin 2006). Secondary OA, or post-traumatic OA (PTOA) is due to a particular insult
that damages the joint, increasing the probability that the injured individual will develop
OA (Ratcliffe, Israel et al. 1998; Buckwalter and Martin 2006). A Traumatic joint injury
that causes a tear in the ligament or meniscus is one biomechanical risk factor that most
commonly causes secondary OA development, in young adults (Roos 2005; Lohmander,
Englund et al. 2007). Underlying congenital abnormalities such as hip dysplasia can also
result in secondary OA (Ganz, Leunig et al. 2008). Regardless of OA classification, the
disease state is very similar at the histological level, particularly in the later stages of OA.

1.1.2

Synovial Joint
Synovial joints are specialized organs, designed to allow near-frictionless

movement between two or more skeletal components (Figure 1.1) (Archer, Dowthwaite
et al. 2003). The ends of diarthrodial joints (epiphysis) in humans is covered by a layer of
articular cartilage, usually a few millimeters thick (Shepherd and Seedhom 1999).
Located directly beneath the articular cartilage is the subchondral bone, which contains
the bone marrow. The synovial membrane contains synoviocytes, which are highly
metabolically active cells located at the surface of the membrane (Aigner, Sachse et al.
2006). Fluids secreted by the synoviocytes comprise the synovial fluid that provides
lubrication between the articular surfaces of the joint (Aigner, Sachse et al. 2006;
Schmidt, Gastelum et al. 2007). The joint capsule acts as a seal to help contain synovial
fluid in position, and with help from connective tissues, provides joint stability by
limiting movement (Ralphs and Benjamin 1994; Aigner, Sachse et al. 2006). All the
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Healthy Knee Joint

Osteoarthritic Knee Joint

Degenerating Cartilage
Joint Capsule

Synovial Inflammation

Articular Cartilage

Osteophyte
Subchondral bone sclerosis

Subchondral Bone

Figure 1.1 Diagram of a healthy and osteoarthritic synovial joint
The synovial joint is a specialized organ commonly affected by OA. The components of a
healthy synovial joint (left) include the articular cartilage (pink), subchondral bone, joint
capsule (purple), and the synovial membrane (which lines the joint capsule). A synovial
joint affected by OA (right) can show one or more of the following features: damaged
articular cartilage (pink), thickening of the subchondral bone (green), osteophytes (blue)
and inflammation of the synovial membrane (dark pink).
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components of the synovial joint must work together to provide functionality and stability
during joint movement.

1.1.3

Tissues Affected by Osteoarthritis
The hallmark of OA is usually articular cartilage degeneration, although it is now

known the disease can affect all tissues of the synovial joint, including the synovial
membrane and subchondral bone. While typically inflammation is more characteristic of
rheumatoid arthritis (RA), a portion of OA cases have reported inflammation in the
synovial membrane (synovitis) (Lindblad and Hedfors 1987). Joint effusions, which can
be caused by trauma, and synovial thickening were both associated with pain symptoms
seen in patients knee OA (Hill, Gale et al. 2001). MRI studies have shown that popliteal
(Baker’s) cysts, which is swelling of the synovial bursa, are frequently observed in
patients with knee OA (Guermazi, Zaim et al. 2003).
Subchondral bone remodeling can also indicate OA progression. Several animal
studies have shown that thickening of the subchondral bone is indicative of OA
development (Carlson, Loeser et al. 1994; Bendele 2001). Subchondral bone thickening
has also been shown to be a predictor for joint space narrowing in patients with knee OA
(Bruyere, Dardenne et al. 2003). In more progressive cases of OA, joint space narrowing
and boney spurs called osteophytes are observed (Figure 1.1) (Ledingham, Regan et al.
1995; Aigner, Sachse et al. 2006). The formation of osteophytes may be an attempt to
confer stability to the deteriorating joint, although the presence of osteophytes can be
associated with joint pain and loss of mobility experienced by individuals with OA
(Pottenger, Phillips et al. 1990; Blom, van Lent et al. 2004). The involvement of multiple
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tissues OA truly demonstrates the complexity of the disease, and the need for active
exploration in all areas of the OA field of research.
1.1.4

Treatment
There is no cure for OA and treatment is challenging, as there are currently no

disease modifying drugs or therapies available that completely hinder OA progression
and the associated symptoms. Typically, treatments attempt to alleviate symptoms that
cause pain after the disease has already progressed. Preventative treatment would be
ideal, although this is not currently feasible as there is very little known about the exact
pathogenesis of the disease. Patients with knee OA have found that weight loss not only
reduces the pain associated with OA, but also improves joint mobility and function
(Bijlsma and Knahr 2007; Ringdahl and Pandit 2011). Loosing weight, or maintaining a
normal BMI, will not prevent OA completely, but it has been shown to slow OA
progression (Aaboe, Bliddal et al. 2011). Topical and oral non-steroidal antiinflammatory drugs (NSAIDS) are another form of treatment commonly used to treat OA
pain (Schnitzer 2002; Barthel and Axford-Gatley 2010).

In severe cases joint

replacement is done, although this is generally seen as a last resort for individuals with
end-stage OA. Several factors can act alone or in tandem to induce OA, making the
underlying mechanisms of this multifaceted disease difficult to understand. Identification
of genes, molecular pathways and biomechanical factors involved in the pathogenesis of
OA is a crucial step towards developing therapies to combat this degenerative joint
disorder.
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1.2

Articular Cartilage
Typically OA affects articular joints such as the knees, hips and hands. The

hallmark of OA is the degradation of articular cartilage, a specialized tissue located at
surface of diarthrodial joints (Figure 1.1) (Aigner, Sachse et al. 2006). The purpose of
articular cartilage is to provide cushioning and to act as a shock absorber for diarthrodial
joints. An individual with healthy articular cartilage will have controlled and frictionless
movement. An individual with OA will have degeneration of the articular cartilage,
which will eventually cause pain and hinder joint mobility and function. The composition
of articular cartilage is fairly homogeneous. The majority of the tissue, over 90 percent, is
comprised of an extracellular matrix (ECM) (Figure 1.2) (Cohen, Foster et al. 1998;
Aigner, Sachse et al. 2006). Contained within the matrix are cartilaginous cells called
chondrocytes (Figure 1.2) (Cohen, Foster et al. 1998; Aigner, Sachse et al. 2006).
The homeostasis of articular cartilage is highly dependent on the balance between
matrix synthesis (anabolism) and matrix degradation (catabolism) (Eyre 2004). In
unhealthy cartilage this balance is lost, causing a shift towards catabolism and ultimately
leading to cartilage matrix degradation (Eyre 2004; Aigner, Sachse et al. 2006). The first
signs of OA generally begin with fibrillation at the cartilage surface, and eventually
progressing to vertical clefts and cartilage erosion, sometimes denuded to the subchondral
bone in later stages of OA (Poole 1999).
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Chondrocytes
ECM

Subchondral
Bone

Figure 1.2 Articular Cartilage Histology
Safranin-O staining of mouse articular cartilage depicts the two distinct components of
articular cartilage. Chondrocytes, the only cell type in articular cartilage, are surrounded
by the extracellular matrix (ECM), which contains collagen and non-collagen proteins
such as proteoglycans. Development of OA involves numerous changes in both the
chondrocytes and ECM.
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1.2.1

Extracellular Matrix
The ECM is a highly specialized component of articular cartilage containing

collagen and non-collagen proteins, such as proteoglycans (Goldring and Marcu 2009).
Several collagen types are found within the ECM, although collagen II is the most
abundant as it comprises over 90 percent of matrix collagen (Cohen, Foster et al. 1998;
Temenoff and Mikos 2000). A fibrocartilage network is formed due to the interactions
between type-II, IX and XI collagens, giving articular cartilage structure and tensile
strength (Cohen, Foster et al. 1998). Osteoarthritic cartilage was found to have denatured
type-II collagen, along with decreased stiffness of the collagen network reducing the
cartilages tensile strength (Hollander, Heathfield et al. 1994; Bank, Soudry et al. 2000).
The majority of the space between the fibrillar collagen mesh is filled with large
aggregating proteoglycan (aggrecan) molecules, which contribute to the stiffness and
durability of cartilage under compression (Buckwalter and Mankin 1998). The main
proteoglycan in articular cartilage is aggrecan, which has a protein core with covalently
attached glycosaminoglycan (GAG) side chains such as chondroitin sulfate, keratin
sulfate and heparan sulfate (Hardingham and Fosang 1992; Cohen, Foster et al. 1998).
The GAG side chains give aggrecan a negative charge, allowing it to attract water
molecules into the tissue (Aigner, Sachse et al. 2006). The water is retained within the
collagen network where it provides resilience and strength as the articular cartilage
undergoes compression (Laasanen, Toyras et al. 2003; Aigner, Sachse et al. 2006). In the
early stages of OA, proteoglycan loss is commonly seen, along with a reduction in
cartilage stiffness (Buckwalter and Lappin 2000; Martin and Buckwalter 2002). Thus,
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changes to the ECM can potentially accelerate the pathogenesis of OA (Martin and
Buckwalter 2002).

1.2.2

Chondrocytes
Chondrocytes, the only cell type found in articular cartilage, reside in the ECM

and only comprise about two percent of the total cartilage volume in humans (Poole,
Kojima et al. 2001). Along with being a hypocellular tissue, articular cartilage is also
avascular and alymphatic, so the turnover of ECM components depends solely on the
chondrocytes (Aigner, Sachse et al. 2006; Chiang and Jiang 2009). As chondrocytes
mature they reduce their metabolic activity, which, in conjunction with a lack of
vascularization means that articular cartilage is slow to repair any damage that occurs
(Buckwalter and Mankin 1998; Aigner, Sachse et al. 2006; van Osch, Brittberg et al.
2009).
The process of developing OA involves numerous changes in chondrocyte
phenotype and metabolism. An early indicator of OA is increased chondrocyte
proliferation, which is usually documented by cell clustering (Rothwell and Bentley
1973; Goggs, Carter et al. 2003). Chondrocyte proliferation is seen as an attempt to repair
damaged cartilage, but is usually unsuccessful in stopping overall progression of OA
(Rothwell and Bentley 1973; Goldring 2006). Damaged cartilage also causes
chondrocytes

to

increase

production

of

catabolic

factors,

such

as

matrix

metalloproteinases (MMPs), which further contributes to the development of OA (Ryu,
Treadwell et al. 1984). Phenotypic changes to chondrocytes, such as hypertrophy, can
also lead to an increase in catabolic enzyme production (van der Kraan and van den Berg
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2012). Together, these changes in chondrocyte function can contribute to the
development and progression of OA.

1.2.3

Zones of Articular Cartilage
Articular cartilage can be divided into 3 or 4 distinct layers, for simplicity only the

superficial zone (SZ), middle zone (MZ) and the deep zone (DZ) will be discussed
(Figure 1.3) (Guilak, Ratcliffe et al. 1995; Pearle, Warren et al. 2005). Each zone has a
distinct ECM and cellular composition, and they all work together to contribute to the
functionality of articular cartilage (Temenoff and Mikos 2000).
The SZ, the thinnest of all three layers, provides the gliding and shear-resistant
surface of the articular joint (Pearle, Warren et al. 2005). This zone has the highest
collagen content, thus the collagen fibers are densely packed together (Pearle, Warren et
al. 2005). Both the collagen fibers and chondrocytes, which have an elongated
appearance, are in parallel with the articular surface (Schumacher, Block et al. 1994;
Klein, Malda et al. 2009). The MZ has a higher compressive strength than the SZ and less
collagen fibril organization (Klein, Malda et al. 2009). The collagen fibers are thicker and
less organized than collagen in the SZ (Cohen, Foster et al. 1998; Pearle, Warren et al.
2005). Chondrocytes in this layer are more rounded and are arranged throughout the
loosely packed collagen fibers with no particular organization (Palfrey and Davies 1966;
Zanetti, Ratcliffe et al. 1985; Pearle, Warren et al. 2005). The DZ has the highest
compressive strength of any of the layers, along with the highest proteoglycan content
(Pearle, Warren et al. 2005). The thickest collagen fibers are found in the DZ, arranged
perpendicularly to the subchondral bone
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SZ

MZ

DZ

Tidemark
Calcified Cartilage
Subchondral Bone

Figure 1.3 Zones of Articular Cartilage
Articular cartilage can be divided into three zones, each identified by appearance and
orientation of the chondrocytes and collagen fibers. The superficial zone (SZ) contains
flattened chondrocytes and tightly packed collagen fibers that are both oriented parallel to
the articular surface. The middle zone (MZ) contains more rounded chondrocytes that are
surround by collagen fibers with no particular organization. The deep zone (DZ) contains
chondrocytes organized in columns that are surrounded by thick collagen fibers, and both
are arranged perpendicular to the cartilage surface. The tidemark acts as a dividing line
between the articular cartilage, and calcified cartilage below. Finally, beneath the
cartilage lies the subchondral bone.
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(Pearle, Warren et al. 2005; Klein, Malda et al. 2009). Chondrocytes in this zone are
larger, more organized and arranged in vertical columns in the same orientation as the
collagen fibers (Palfrey and Davies 1966; Klein, Malda et al. 2009). A layer of calcified
cartilage can be found between the DZ and the subchondral bone (Poole, Kojima et al.
2001). A histologically visible line known as the tidemark separates the uncalcified
cartilage of the DZ from the calcified cartilage layer beneath it (Minns and Steven 1977;
Poole, Kojima et al. 2001).

1.3

Aging and Osteoarthritis
Aging and obesity are considered to be the most common risk factors contributing

to the development of OA (Felson, Lawrence et al. 2000). Aging, unlike obesity, is
obviously inevitable, and with the increasing age of the population, rates of OA are only
expected to rise. Approximately 25 percent of individuals in their sixties and over 50
percent of individuals over 80 have radiographic signs of OA, which clearly demonstrates
aging is a large risk factor for OA development (Das and Farooqi 2008). While aging
greatly increases the risk of developing OA, getting older does not guarantee an
individual will develop OA (Loeser 2011). One study found that 16 percent of
participants over the age of 90 had no radiographic signs of OA (Goekoop, Kloppenburg
et al. 2011).
Many theories have attempted to describe the correlation between aging and OA,
but the issue is still controversial. The continuous loading or “wear and tear” theory is the
most common explanation for age-induced OA. The mechanical condition occurs due to
repetitive use and joint loading, which over time damages the joints and leads to OA
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(Aigner and Richter 2012). Age related changes to the ECM of articular cartilage can also
contribute to the joint’s ability to deal with repetition and loading (Aigner and Richter
2012). An increase in advanced glycation end products (AGEs) causes crosslinking in
articular cartilage, which stiffens the tissue making the cartilage more susceptible to
mechanical damage (Verzijl, DeGroot et al. 2002; Leong and Sun 2011).
Reduced responsiveness of chondrocytes to anabolic factors with age is another
theory that might explain why elderly individuals develop OA (Loeser 2011). Insulin-like
growth factor-1 (IGF-1) is one of the most widely studied growth factors and is the main
anabolic signal in articular cartilage (Schmidt, Chen et al. 2006; Fortier, Barker et al.
2011). The homeostasis of proteoglycans is heavily influenced by IGF-1, which has been
shown to hinder their breakdown (Hickey, Frenkel et al. 2003). IGF-1 has also been
found to promote the synthesis of proteoglycans in the presence of proinflammatory
cytokines (Tyler 1989). Furthermore, knee joints of rats deficient in IGF-1 have more
severe OA lesions than rats with normal IGF-1 levels (Ekenstedt, Sonntag et al. 2006).
Aging has been found to decrease chondrocyte responsiveness to anabolic growth
factors like IGF-1. Although this effect is not completely understood, several studies have
proposed that increased levels of reactive oxygen species (ROS) may be involved (Loeser
2011). The amount of oxidative stress increases with age, and will ultimately lead to
more ROS, which has been shown to induce chondrocyte senescence (Brandl, Hartmann
et al. 2011). Senescence of chondrocytes is known to disrupt homeostasis in the cartilage
matrix and lead to degeneration of articular cartilage, causing OA (Loeser 2009). The
age-related reduced responsiveness of cartilage to anabolic factors like IGF-1 could be
partly explained by the chondrocyte senescence theory (Loeser 2009; Loeser 2011). Due
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to the complexity of OA, these theories may need to be considered in tandem, rather than
individually, to explain the age related effects that lead to the onset of OA.

1.4

Obesity and Osteoarthritis
Obesity, defined as a having body mass index of thirty or above, is the number

one preventable risk factor of OA (Powell, Teichtahl et al. 2005; Lau, Douketis et al.
2007). The prevalence of obesity in North America is increasing at an alarming rate. In
2012, over 18 percent of Canadian adults were considered to be obese, and this number is
expected to rise (Statistics Canada 2012). Health care expenditures directly attributed to
obesity total approximately 4 billion dollars annually, while costs due to comorbidities
associated with obesity can increase these health care expenditures by another 25 percent
(Anis, Zhang et al. 2010).
For the most part, obesity has become an issue simply because energy intake is
much greater than energy expenditure. It is well known that a reduction in overall caloric
intake coupled with increased energy expenditure is guaranteed to lower body weight,
while improving health and fitness. Genetic predisposition to obesity is a contributing
factor to the current epidemic, although in most cases obesity is caused by higher caloric
diets and a sedentary lifestyle (Ravussin, Valencia et al. 1994; Rankinen, Zuberi et al.
2006). Unfortunately for many people it can be difficult to overcome obesity, leaving
many obese individuals struggling with serious health issues.
Hypertension, heart disease, type II diabetes and OA are just some of the
comorbidities associated with obesity (Guh, Zhang et al. 2009). Being obese does not
guarantee and individual will get OA, but it is still considered a large risk factor (Sowers
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and Karvonen-Gutierrez 2010). Excess weight due to obesity has been suggested to
increase the mechanical load on joints, therefore leading to a higher instance of OA
(Sturmer, Gunther et al. 2000). However this increased biomechanical loading does not
explain why obese individuals see an increase in hand OA, since hand joints are
considered non-load bearing (Dahaghin, Bierma-Zeinstra et al. 2007).
Obesity is synonymous with having an excess of adipose tissue, a connective
tissue composed of adipocytes that has recently been classified as an endocrine organ
(Kershaw and Flier 2004). Adipose tissue secretes protein hormones such as leptin, a
factor that has been shown to regulate chondrocyte differentiation and has been found in
large quantities in osteophytes (Kishida, Hirao et al. 2005; Presle, Pottie et al. 2006).
Studies of leptin have shown that obesity-associated OA may act through systemic
effects, rather than mechanical loading. Leptin-deficient mice become extremely obese
but do not show an increase in knee OA, suggesting that leptin rather than weight gain
per se might contribute to OA risk (Griffin, Huebner et al. 2009). It is now understood
that obesity may contribute to the pathogenesis of OA through both biomechanical
loading and systemic effects (Sowers and Karvonen-Gutierrez 2010).

1.5

Mouse Models in Osteoarthritis
Animal models have been used for decades to investigate the underlying

mechanisms responsible for the pathogenesis of OA. Mouse models are particularly
useful as they can be genetically modified, share high sequence homology with humans,
and are relatively inexpensive to maintain. While there are many mouse models available
for OA, relatively few have been used to study the effects of obesity in OA (Griffin and
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Guilak 2008).
The C57Bl/6J mouse line is the most widely used strain as it has many favorable
characteristics that are applicable to many areas of research, including obesity and OA
(Battey, Jordan et al. 1999). It was one of the first strains to be used to study the effects of
a high fat diet on OA development (Silberberg and Silberberg 1950). This strain is
susceptible to obesity when fed a high fat diet, which can lead to a myriad of changes
including hypertension, hyperglycemia, hyperinsulinemia and even a compromised
immune system (Crevel, Friend et al. 1992; Collins, Martin et al. 2004). Feeding
C57BL/6J mice a high-fat diet was found to increase the rate of OA 2-fold, and the onset
of OA was found at earlier time points than in control mice (Silberberg and Silberberg
1950). Another study using a 45 percent fat diet found that C57BL/6J mice were highly
susceptible to musculoskeletal and behavioral changes associated with OA development
(Griffin, Fermor et al. 2010).
The susceptibility of the C57BL/6J strain to development of OA, without
alteration in diet, has also made it a particularly useful model to study the effect of aging
on spontaneous OA development (Wilhelmi and Faust 1976). The instance and severity
of OA was found to increase with age in mice up to 16 months old, and was identified by
a reduction in proteoglycans and disturbed collagen networks (Yamamoto, Shishido et al.
2005). In humans, OA usually occurs more frequently in adults and the instance of OA
gradually increases with age. The C57BL/6J mouse model has been found to closely
resemble the onset of OA seen in humans, making it the most suitable mouse model to
study spontaneous OA progression (Yamamoto, Shishido et al. 2005).
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1.5.1

Evaluating Osteoarthritis in Mice
Mouse models are extremely useful in all fields of OA research. Due to the

variability of OA, several methods have been standardized to allow for evaluation of
disease progression over a wide variety of mouse models. Histological assessment,
involving the fixing, processing and staining of animal tissue, is commonly used to
determine OA progression in mice. The knee is often studied in mice as it is a relatively
large joint and is usually the primary site for spontaneous OA development (Glasson,
Chambers et al. 2010). Since articular cartilage degeneration is often seen in OA,
Safranin-O staining is a commonly used technique, as it specifically stains
glycosaminoglycan rich cartilage (Rosenberg 1971). Safranin-O staining is often done in
tandem with Fast Green, a cytoplasmic counterstain, and Hematoxylin which stains the
nuclei a dark purple (Rosenberg 1971).
Although Safranin-O staining is useful for identifying damage to the articular
cartilage, it is usually used in tandem with a standardized grading system for OA. There
are generally different grading systems for each animal species, as differences in cartilage
would make it difficult to standardize scoring methods. For mice, the Osteoarthritis
Research Society International (OARSI) scoring system is a commonly used method for
determining a semi-quantitative score for the histopathological assessment of OA in the
knee (Glasson, Chambers et al. 2010). This scoring protocol assigns a numbered score to
each of the 4 quadrants of the knee, medial femoral condyle (MFC), medial tibial plateau
(MTP), lateral femoral condyle (LFC) and lateral tibial plateau (LTP) (Figure 1.4).
OARSI scores range from 0, no OA, to 6, severe OA characterized by erosion down to
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the calcified cartilage that covers over 75 percent of the articular surface (Glasson,
Chambers et al. 2010).
Examination of structural changes alone cannot determine effects of OA on
overall joint function, and it has become increasingly important to investigate the
functional changes that occur with OA development. Gait analysis can be used to detect
disturbances from a normal gait pattern in mice (Clarke and Still 2001). When used in
combination with histological scoring, gait analysis can determine functional changes that
may be associated with OA development.

1.6

Growth Factors
Growth factors are a large group of naturally occurring extracellular polypeptides

that have the ability to stimulate cellular division, proliferation and differentiation (Nimni
1997). Growth factors are signaling molecules that generally act through cell-to-cell
communication via paracrine and endocrine signaling, but can also be involved in
juxtacrine and autocrine cell signaling (Nimni 1997). Individual growth factors typically
belong to a larger family of structurally and/or evolutionarily related growth factor
proteins.

Many different growth factors have been targeted for use in therapeutic

treatments for a wide range of diseases, including OA, as there are many growth factors
involved the development and homeostasis of articular cartilage (Trippel 1995; Linkhart,
Mohan et al. 1996; Trippel 2004).

1.6.1

Epidermal Growth Factor Family
The epidermal growth factor (EGF) family is a class of ligands that have the
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Figure 1.4 The OARSI scoring system grades individual knee quadrants
The OARSI scoring system assigns a grade to Safranin-O stained knee sections to assess
OA progression in the mouse knee. Scores are assigned to each of the knee quadrants,
which are the medial femoral condyle (MFC), lateral femoral condyle (LFC), medial
tibial plateau (MTP) and the lateral tibial plateau (LTP). This diagram depicts a healthy
mouse knee, which would receive an OARSI score of 0.
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ability to bind and activate the epidermal growth factor receptor (EGFR). The founding
member of this family is EGF, other members include Transforming growth factor-alpha
(TGFα), Heparin-binding EGF-like growth factor (HB-EGF), epiregulin (EPR),
amphiregulin (AR) and several others (Salomon, Brandt et al. 1995; Edwin, Wiepz et al.
2006). All members of the EGF family share high structural and functional similarities,
such as six conserved cysteine residues that form three disulphide bonds (Nagata, Kohda
et al. 1994; Barbacci, Guarino et al. 1995). These disulphide bonds are necessary for
forming the high-affinity binding that occurs with the EGFR, indicating the importance
of conservation in the EGF family (Barbacci, Guarino et al. 1995).

1.6.2

Epidermal Growth Factor Receptor
The EGFR is a highly conserved transmembrane protein that belongs to the

protein kinase superfamily. The EGFR is the founding member of 4 closely related
receptor tyrosine kinases (RTK) that include ErbB1 (EGFR), ErbB2, ErbB3 and ErbB4
(Prigent and Lemoine 1992; Plowman, Culouscou et al. 1993). When EGF ligands bind
to the EGFR it causes homo- or heterodimerization, which stimulates intrinsic tyrosinekinase activity leading to auto-phosphorylation of certain tyrosine residues on the
receptor (Wells 1999; Schlessinger 2000). Activation of the EGFR can initiate a number
of downstream signaling cascades, including the ras/raf/mitogen activated kinase
(MAPK), phosphatidylinositol 3-kinase (PI3K)/Akt and Rho-GTPase pathways (Bogdan
and Klambt 2001; Jorissen, Walker et al. 2003; Appleton, Usmani et al. 2010).
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1.6.3

Transforming growth factor alpha
TGFα, a member of the EGF family, shares approximately 40 percent sequence

homology EGF (Mead and Fausto 1989). This shared homology is the basis of
competition between TGFα and EGF to bind to the EGFR (Harris, Chung et al. 2003).
TGFα is derived from a large 160 amino acid transmembrane precursor (Pro-TGFα)
molecule, and must be cleaved to create its mature and soluble 50 amino acid length form
(Derynck, Roberts et al. 1984; Kumar, Bustin et al. 1995). Once cleaved, the soluble form
of TGFα is able to bind to the EGFR via autocrine or paracrine signaling (Kumar, Bustin
et al. 1995). Membrane bound forms of TGFα can activate EGFR in adjacent cells, which
is known as juxtacrine signaling (Kumar, Bustin et al. 1995).
TGFα was originally discovered in cultured media from murine sarcoma virus(MuSV) transformed fibroblasts (de Larco and Todaro 1978). Transforming growth
factor beta (TGFβ) was discovered at the same time as TGFα, thus giving the two
proteins similar names, although they are structurally unrelated and bind to different
receptors (de Larco and Todaro 1978; Cheifetz, Weatherbee et al. 1987). TGFα is a key
mitogenic protein that is involved in normal growth and development, specifically in
regards to cell proliferation, migration and differentiation and in chondrogenesis
(Groenen, Nice et al. 1994; Huang, Solursh et al. 1996). TGFα is also well characterized
for its role in the inflammatory response brought on by infection (Groenen, Nice et al.
1994). A number of embryonic and adult tissues such as the brain, liver, colon, kidney,
skin and gastric mucosa, have been found to express TGFα (Derynck 1992; Kumar,
Bustin et al. 1995).
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To further understand the role of TGFα in vivo, several mutant mouse models
involving TGFα have been developed. Transgenic mice engineered to overexpress TGFα
under the control of a zinc-inducible mouse metallothionein promoter were found to have
increased liver mass and hepatocyte production (Webber, Wu et al. 1994). TGFα null
mice were found to have a very obvious wavy hair phenotype, likely due to the
disorganization of their hair follicles (Mann, Fowler et al. 1993). The same TGFα null
mice develop curly whiskers just after birth and are also more prone to developing
corneal inflammation (Mann, Fowler et al. 1993). Our lab found that TGFα null mice
under 10 weeks of age have delayed skeletal growth along with expanded hypertrophic
zones of the growth plates (Usmani, Pest et al. 2012). The same mice experience catch-up
growth by 10 weeks of age, and are known to have relatively normal post-natal
development (Mann, Fowler et al. 1993; Usmani, Pest et al. 2012).

1.6.4

Transforming growth factor alpha in Osteoarthritis
Our lab has identified TGFα as a growth factor that may significantly influence

the pathogenesis of OA. Microarray experiments using degenerating articular cartilage in
a surgical rat model of OA have shown an increase in Tgfa expression in osteoarthritic rat
cartilage (Appleton, McErlain et al. 2007). Our collaborators have also identified a subset
of patients with late stage OA that have an increase in TGFα mRNA expression in knee
cartilage, further indicating the importance of understanding the role of TGFα in OA
development (Appleton, Usmani et al. 2007). It is important to note that TGFα has been
also been found in the synovial membrane and synovial fluid of OA patients, but these
levels are typically higher in patients with RA (Hallbeck, Walz et al. 2005).
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Since identifying TGFα in the disease state of OA, it was important to further
determine the specific role of this factor in OA. In vitro studies done in our lab using
primary rat articular chondrocyte cultures have shown that TGFα reduces anabolic gene
expression, while also promoting catabolic processes (Appleton, Usmani et al. 2007).
This disruption of cartilage homeostasis can ultimately lead to cartilage degradation and
OA development. TGFα treated cultures also showed altered chondrocyte morphology, a
phenotype that is often observed in osteoarthritic cartilage (Appleton, Usmani et al.
2007).
Overactivation of EGFR by disruption of the mitogen-inducible 6 (Mig6) gene
has been shown cause OA pathogenesis in mice (Zhang, Su et al. 2005). Since TGFα
plays a large role in EGFR signaling it is important to look at other pathways downstream
of EGFR to better understand TGFα influence in OA development (Kumar, Bustin et al.
1995). Our lab used inhibitors to block the MEK/ERK portion of the MAPK pathway and
the RhoA/ROCK pathway, both of which are downstream from the EGFR signaling
pathway (Appleton, Usmani et al. 2010). Inhibition of the MEK/ERK pathway blocked
the reduction of anabolic gene expression, while inhibiting the RhoA/ROCK pathway
stopped changes to chondrocyte morphology (Appleton, Usmani et al. 2010). These
demonstrations of disruptions of TGFα-induced changes via inhibition of downstream
EGFR pathways, highlight the importance of TGFα in OA pathogenesis.
Since TGFα is associated with the diseased state of OA, our lab investigated if a
lack of TGFα could be associated with a decrease in OA progression. Recently submitted
results from one of our lab members, Dr. Shirine Usmani, indicate that loss of Tgfa in
mice provides protective effects against surgically induced OA (Figure 1.5). This data

24

suggests that TGFα may be a potential therapeutic target for treatment of PTOA.
Identifying a role for TGFα in aging- and obesity-associated OA would further define the
importance of this gene for therapeutic targeting.

1.7

Objectives and Hypothesis
We hypothesize that the Tgfa null mouse line available in our lab will be

protected against obesity-induced OA. Currently there is no data about the role of TGFα
in obesity-associated OA.
We further hypothesize that aged mice will have a higher occurrence and/or
higher severity of OA.

Specific objectives of this thesis are to:

1.

Investigate if genetically modified mice lacking Tgfa are protected
against obesity-associated OA

2.

Determine the rate of spontaneous OA in aging C57BL/6J mice
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Figure 1.5 Tgfa null mice are protected from post-traumatic OA
Surgery to destabilize the medial meniscus (DMM) was given to control mice
heterozygous for Tgfa and to Tgfa null littermates. Seven weeks post-surgery, Safranin-O
staining (A) demonstrates more articular cartilage damage in mice heterozygous for Tgfa
when compared to Tgfa null mice. Safranin-O stained sections were then graded utilizing
an OARSI scoring system (B). Tgfa null mice have significantly lower OA scores,
indicating protection from post-traumatic OA. Image courtesy of Dr. Shirine Usmani
(Appleton et al., submitted).
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2.0 METHODS
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2.1

Transforming growth factor-alpha knockout mice
Tgfa null mice were purchased from The Jackson Laboratory (Bar Harbor, ME,

USA). All animals were bred and cared for in accordance with the University of Western
Ontario’s Animal Care and Use Guidelines. Heterozygous breeding pairs were set up to
obtain offspring with wild type (Tgfa +/+), heterozygous (Tgfa

+/–

) and null (Tgfa

–/–

)

genotypes. Polymerase chain reaction (PCR) genotyping was performed using DNA
digested from ear notches taken when the mice were at weaning age. Two separate PCR
programs were used to amplify the wild type Tgfa allele and the neo-cassette found in the
mutated alleles. Oligonucleotides TGFalphaA (5’-GACTAGCCTGGGCTA
CACA GTG-3’) and TGFalphaC (5’-ACATGCTGGCTTCTCTTCCTGC-3’) were used
for amplification of the wild type Tgfα allele. Oligonucleotides NeoForward (5’-CTTGG
GTGGAGAGGC TATTC-3’) and NeoReverse (5’-AGGTGAGATGACAGGAGATC3’) were used for amplification of the neo-cassette found in Tgfa null mice. All
oligonucleotides were purchased from Sigma-Aldrich (Oakville, ON, Canada) and all
other genotyping reagents were purchased from Applied Biosystems Incorporated (Foster
City, CA, USA).

2.2

Housing and Diet for Obesity Studies
Female and male littermate trials were kept on regular chow and housed in

corncob bedding until they reached 9 weeks of age. A trial consisted of at least 2 control
(Tgfa +/+ or Tgfa+/–) and 2 Tgfa null mice. At 9 weeks the mice in each trial were split up
according to genotype and fed either a high fat (45% of calories from fat) or low fat
control (10% of calories from fat) diet, and were housed in beta chip bedding until they
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reached 54 weeks of age. High fat (TD.06415) and low fat (TD.06416) diet food pellets
were purchased from Harlan Laboratories (Madison, WI, USA).

2.3

C57BL/6J Mice
Male and female C57BL/6J were obtained from Charles River (MA, USA), and

generously donated by Kevin Barr from the Laird and Kidder laboratories at the
University of Western Ontario (London, ON, Canada). Mice were obtained at various
ages and kept until appropriate time points were reached. Mice were fed normal chow
and housed in corncob bedding.

2.4

Quantitative Magnetic Resonance
Quantitative Magnetic Resonance (QMR) method was used to determine total fat

and lean mass to evaluate body composition of mice prior to sacrifice (Echo Medical
Systems, LLC, Houston, TX). This machine and method have been previously used to
accurately determine the fat and lean body mass composition in mice (Nunn, Zhao et al.
2011). Dr. Christopher Guglielmo generously provided access to the QMR machine
located at the Advanced Facility for Avian Research (AFAR) (London, ON, Canada). A
systems test and 3g oil calibration was performed before the mice were scanned. Each
mouse was scanned twice, approximately 2 minutes per scan. The average values
obtained from the scans were used for statistical analysis.
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2.5

Gait Analysis
Gait analysis utilized the CatWalk system (Noldus Information Technology, VA)

at the Robarts Research Institute Behavioral Facility to detect any changes in gait patterns
(London, ON, Canada). Mice were individually recorded in 20-second intervals and were
monitored during recording to ensure that at least 6 touchdowns of each paw occurred.
Only runs where mice continuously walked across the CatWalk apparatus were saved.
Labeling of the paws was done with CatWalk 7.1 software and the pre process threshold
was set to 75 (Noldus Information Technology, VA). A minimum of three runs per
mouse were averaged, and this average was used for statistical analysis of paw intensity,
stride length (mm) and swing speed (m/s) gait parameters.

2.6

Blood Collection and Plasma Analysis
All mice were fasted 5 hours prior to sacrifice. Cardiac puncture was performed at

the time of sacrifice to obtain the maximum amount of blood from each mouse.
Approximately 35 µl of 7% ethylenediaminetetraacetic acid (EDTA) was put into a 1cc
syringe before blood collection to ensure the blood would not clot. A 23 gauge, ¾ inch
length needle was used for cardiac puncture. Blood glucose readings were taken
immediately after cardiac puncture with a Bayer Contour® meter and strips. Blood was
transferred into 1.5 ml Eppendorf tubes on ice and inverted twice to ensure the EDTA
was evenly distributed. All the blood collected was centrifuged at 4ºC for 5 minutes at
14000 rpm to separate plasma. Plasma was aliquoted and frozen at -20ºC. Plasma was
sent to the Metabolic Phenotyping Laboratory at the Robarts Research Institute and
circulating levels of triglycerides and cholesterol were analyzed (London, ON, Canada).
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2.7

Tissue Processing

2.7.1

Knee
Knee joints from all mice were dissected in Puck’s saline A (PSA) and then fixed

for 24 hours in 4% paraformaldehyde (PFA). After 24 hours, PFA was removed and
joints were placed in a decalcification solution which consisted of 5% EDTA with
phosphate buffered saline (PBS), adjusted to pH 7.0 with sodium hydroxide. Joints were
placed on a rocker at room temperature and EDTA was changed every 3 days.
Decalcification was determined by a physical end-point test, following which tissues
were sent for processing at the Molecular Pathology Laboratory at Robarts Research
Institute (London, ON, Canada). Knees were embedded in a frontal orientation.

2.7.2

Gonadal Fat
Both gonadal fat pads were harvested from female feed study mice. One fat pad

was fixed in 4% PFA to fix for 24 hours and sent to Robarts Molecular Pathology for
processing (London, ON, Canada). The other fat pad was embedded in Tissue-Tek®
O.C.T. (Optimal Cutting Temperature) compound, flash frozen in liquid nitrogen and
kept at -80ºC (Thermo Fisher Scientific, Mississauga, ON, Canada).

2.7.3

Organs
The pancreas, kidneys, liver, heart, brain and skeletal muscle of male and female

feed study mice were dissected out immediately after sacrifice. Total organ weight was
taken for the pancreas, kidneys, liver, heart and brain. Organs were divided into 2
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Eppendorf tubes, one containing 500 µl TRIzol and the other containing 250 µl RIPA
buffer. All organs were flash frozen in liquid nitrogen and stored at -80ºC.

2.8

Histology

2.8.1

Knee
Knee samples were embedded in paraffin, and sectioned at the Robarts Molecular

Pathology Facility (London, ON, Canada). Serial sections 4 µm thick were stained with
Safranin-O to detect areas positive for glycosaminoglycans. After dewaxing and
hydrating, the sections were stained sequentially in Hematoxylin for 1 minute, 0.03 %
Fast Green for 25 minutes followed by 10 washes in acidified water and finally 1.5%
Safranin-O for 3 minutes. Sections were dehydrated and mounted with TBS
SHUR/MountTM xylene based mounting medium (Triangle Biomedical Sciences, NC).

2.8.2

Gonadal Fat
After gonadal fat pads were processed and embedded in paraffin, they were sent

to the Robarts Molecular Pathology Facility for sectioning (London, ON, Canada).
Continuous sections were cut at 4 µm thickness. Hematoxylin and Eosin (H&E) staining
was conducted to better visualize fat cells. After dewaxing and hydrating, sections were
stained with Hematoxylin for 3 minutes and Eosin Y solution, with phloxine, for 1
minute. Sections were dehydrated and mounted with TBS SHUR/MountTM xylene based
mounting medium (Triangle Biomedical Sciences, NC).
After staining, both knees and gonadal fat pads were imaged with a Leica
DFC295 camera, Lecia DM1000 microscope and Leica Application Suite software,
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version 3.8.0 (Leica Microsystems, Richmond Hill, ON, Canada)
2.9

OARSI Scoring
Experienced, blinded observers assigned a semi-quantitative score to Safranin-O

stained frontally embedded knee sections of both the feed study and aging C57BL/6J
mice, based on the OARSI recommendations for grading OA development in the mouse
(Glasson, Chambers et al. 2010). A total of 4 non-serial sections were used to score the
medial femoral condyle (MFC), lateral femoral condyle (LFC), medial tibial plateau
(MTP) and the lateral tibial plateau (LTP) of each animal, and the scores from the 4
sections were averaged for each animal. An overall OARSI score of the whole knee, and
individual OARSI scores of the 4 quadrants were obtained.

2.10

Statistics
All statistical analyses were performed using GraphPad Prism software version

5.0a. Feed study trial statistics were analyzed using a two-way analysis of variance
(ANOVA) with a Bonferroni’s post-test. Statistics for C57BL/6J male and female mice
were analyzed using a one-way ANOVA with a Tukey’s post-test. All graphs show mean
values + standard error of the mean (SEM). Statistics were performed on log-transformed
data when appropriate. A minimum of three independent samples was used in all
statistical analyses.
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3.0 RESULTS
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3.1

Tgfa null mice on the high fat diet weigh less than controls
Diet induced obesity has been previously shown to lead to OA in wild type mice

(Silberberg and Silberberg 1950; Griffin, Fermor et al. 2010). The diet outlined by Griffin
and colleagues was used to induce obesity in Tgfa null mice to study the effects of
obesity-induced OA. A 45% high fat (HF) and a 10% low fat (LF) control diet were fed
to Tgfa null mice and wild type littermates for a period of 54 weeks. Analysis of food
intake per week was done to measure the average caloric consumption of mice on either
diet, and it was found that the mice did not differ significantly in overall caloric intake
(Figure 3.1). Since mice on the HF diet did not consume more calories than mice on the
LF diet, any weight gain in mice on the HF diet would likely be due to the higher fat
content of their food. An initial growth chart from one representative female trial
demonstrates that Tgfa null mice gain less weight than wild type littermates, regardless of
diet type (Figure 3.2A). However, after comparing all completed female trials, it
appeared that Tgfa null mice on the LF diet did not weigh significantly less than their
wild type littermates (Figure 3.2B). In contrast, Tgfa null mice weighed significantly less
than control mice on the HF diet (Figure 3.2B). After comparing between the two diets I
found that wild type mice on the HF weighed significantly more than wild type mice on
the LF diet (Figure 3.2B). The same result was also observed in the Tgfa null mice as
those on the HF diet weighed significantly more than Tgfa null mice on the LF diet
(Figure 3.2B).

35

Calories consumed (Kcal)

100
80
60
40
20
0
HF

LF

Diet

Figure 3.1 Overall caloric consumption does not differ between diets
The amount of average calories (Kcal) consumed per mouse, each week, was not
significantly different between the LF and HF diets. Average caloric intake of control and
Tgfa null mice were combined and used in statistical analysis (n=6, *P<0.05).
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Figure 3.2 Tgfa null mice on the HF diet weigh less than controls
A growth chart of one representative female feed study trial (A) found that Tgfa null
mice, on both the LF and HF diet, did not gain as much weight as control littermates.
After all trials were completed, statistical analysis of total body weight (B) revealed that
Tgfa null mice weighed less than controls, only on the HF diet. Both control and Tgfa
null mice on the HF diet weighed significantly more than on the LF diet (n=4, *P<0.05).
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3.2

Quantitative Magnetic Resonance shows that Tgfa null mice on the high fat

diet have lower total fat mass
Quantitative Magnetic Resonance (QMR) is a widely tested and approved method
for gathering quick and accurate information about the body composition of live mice
(Nixon, Zhang et al. 2010). Data from QMR confirmed that Tgfa null mice on the HF diet
weighed less than wild type controls, and this was due to a significant reduction in total
fat mass (Figure 3.2B, 3.3A). There were no significant differences in total weight or fat
mass between control and Tgfa null mice on the LF diet (Figure 3.2B, 3.3A). Wild type
mice on the HF had significantly higher fat mass than wild type mice on the LF diet
(Figure 3.3A). The same trend was observed when comparing Tgfa null mice; on the HF
diet Tgfa null mice had significantly higher fat mass than on the LF diet (Figure 3.3A).
Total lean mass, also analyzed by QMR, did not differ significantly between genotypes,
on either diet (Figure 3.3B). There were also no significant differences in total lean mass
of Tgfa null or control mice, after comparing between diets (Figure 3.3B).

3.3

Tgfa null mice on the high fat diet have lower levels circulating cholesterol
Obesity causes a cascade of changes throughout the body, and can lead to

elevated blood glucose (hyperglycemia), cholesterol (hypercholesterolemia) and
triglyceride (hypertriglyceridemia) levels. A number of these metabolic factors, including
high blood glucose and cholesterol levels, have been long associated with OA (Hart,
Doyle et al. 1995; Sturmer, Sun et al. 1998). Plasma analyzed from cardiac puncture
blood collections showed that Tgfa null mice had significantly lower cholesterol levels
than control littermates on the HF diet (Figure 3.4A). There was no difference in
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Figure 3.3 Tgfα null mice on the HF diet have lower total fat mass
Body composition analyzed by QMR revealed that Tgfα null mice weigh less than
controls due to a reduction in fat mass (A), as there was no significant difference
observed in total lean mass (B). Consistent with weight gain data, mice on the HF diet
had significantly higher total fat mass than mice on the LF diet (n=4, *P<0.05).
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Figure 3.4 Tgfα null mice on the HF have lower levels of circulating cholesterol than
controls
Circulating levels of cholesterol (A) and triglycerides (B) were analyzed from plasma
collected by cardiac puncture. Blood glucose (C) levels were taken immediately after
cardiac puncture. Tgfa null mice had significantly lower cholesterol levels than their
control littermates on the HF diet, and control mice on the HF diet had significantly
higher cholesterol levels than control mice on the LF diet. Circulating levels of
triglycerides and blood glucose levels were not significantly different between any of the
mice (n=4, *P<0.05).
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circulating cholesterol levels between control and Tgfa null mice on the LF diet (Figure
3.4A). Control mice on the HF diet had significantly higher cholesterol levels than
control mice on the LF diet (Figure 3.4A). The cholesterol levels between the Tgfa null
mice on the LF and HF diets were not significantly different (Figure 3.4A). There were
no significant differences in circulating triglyceride levels between the genotypes, on
either diet (Figure 3.4B). There were also no significant differences in triglyceride levels
in the control or Tgfa null mice, after comparing between the LF and HF diets (Figure
3.4B). Blood glucose levels taken immediately after cardiac puncture showed no
significant trends between the genotypes, o n either diet (Figure 3.4C). There were also
no significant differences in blood glucose levels of Tgfa null or wild type mice, after
comparing between diets (Figure 3.4C).

3.4

Tgfa null mice have smaller livers and gonadal adipocytes
The liver, pancreas, brain, kidney and heart of the mice were harvested and

weighed. After analyzing the total organ weights, Tgfa null mice were found to have
smaller livers than control littermates, on either diet (Figure 3.5A). There were no
significant differences in the liver weight of Tgfa null or wild type mice, after comparing
between diets (Figure 3.5A).

After comparing between genotypes, there were no

significant weight differences in any of the other collected organs, on either diet (Figure
3.5B-E). There were also no significant weight differences found in the pancreas, brain
and kidney of wild type mice, after comparing between the LF and HF diets (Figure
3.5B-D). However, the hearts of wild type mice on the HF diet weighed significantly
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Figure 3.5 Tgfα null mice livers weigh less than controls
The liver (A), pancreas (B), brain (C), kidney (D) and heart (E) were weighed
immediately after harvesting to obtain the total organ weight. The livers of Tgfα null mice
weighted significantly less than those of control mice, on both the LF and HF diets. The
kidneys of the mutant mice on the HF diet weighed significantly more compared to the
mutant mice on the LF diet. The hearts of the HF control mice weighed significantly
more than in LF control mice (n=4, *P<0.05).

42

A
*

3

Pancreas

0.4

CTRL
KO

CTRL
KO

0.3

2

Weight (g)

Weight (g)

*

B

Liver

1

0.2
0.1
0.0

0
LF

LF

HF

HF

Diet

Diet

C
0.6

Kidney

0.5

CTRL
KO

*

CTRL
KO

0.4
Weight (g)

0.4

0.2

0.3
0.2
0.1

0.0

0.0

LF

HF

LF

HF

Diet

Diet

E

Heart

*

0.20

CTRL
KO

0.15
Weight (g)

Weight (g)

D

Brain

0.10
0.05
0.00
LF

HF

Diet

43

more than the wild type mice on the LF diet (Figure 3.5E). No significant weight
differences were observed in the pancreas, brain and heart of Tgfa null mice, after
comparing between the LF and HF diets (Figure 3.5B,C,E). The Tgfa null mice on the HF
diet had significantly heavier kidneys than Tgfa null mice on the LF diet (Figure 3.5D).
To ensure the results observed for organ size were not due to differences in the
body weights of the mice, the data was normalized to total body weight. The Tgfa null
mice still had significantly smaller livers than control mice on the LF diet, but there was
no difference found between the genotypes on the HF diet (Figure 3.6A). The livers of
control and Tgfa null mice on the LF diet weighed significantly more than the control and
Tgfa null mice on the HF diet (Figure 3.6A). There were no significant weight differences
observed in the pancreas, brain, kidney or heart after comparing between genotypes, on
either diet (Figure 3.6B-E). However, both control and Tgfa null mice on the LF diet had
proportionally significantly heavier brains and kidneys than control and Tgfa null mice on
the HF diet (Figure 3.6C,D). There were no weight differences observed in pancreas or
heart in either the control or Tgfa null mice, after comparing between diets (Figure
3.6B,E).
The brains of control and Tgfa null mice on the LF diet were found to be
proportionally heavier than the brains of control and Tgfa null mice on the HF diet. This
was likely due to normalization to total body weight, since the overall size of the brain
was not altered by diet or genotype (Figure 3.5). The organ weights were then normalized
to total lean mass, which was previously collected by QMR. There were no significant
weight differences observed in the liver, pancreas, brain, kidney or heart after
normalization to total lean mass (Figure 3.7A-E).
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Upon discovering that weight differences between control and Tgfa null mice
were due to fat content from the QMR results, the gonadal fat pads were also collected at
the time of sacrifice. Paraffin sections of the gonadal fat pads were stained with
Hematoxylin and Eosin (H&E). Fat cells from gonadal fat pads appear to be smaller and
more abundant, per area, in Tgfa null mice compared to control littermates, on either diet
(Figure 3.8).
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Figure 3.6 Livers of Tgfα null mice on the LF diet weigh less than controls
To ensure the differences in body weight were not causing the difference in organ size,
the weights of liver (A), pancreas (B), brain (C), kidney (D) and heart (E) were all
normalized to total body weight. After normalization the Tgfa null mice had smaller
livers than controls, but only on the LF diet. The liver, brain and kidneys of control and
Tgfa null mice on the LF diet were proportionally significantly larger than control and
Tgfa null mice on the HF diet (n=4, *P<0.05).
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Figure 3.7 No difference in organ weights after normalization to lean mass
The total organ weights of the liver (A), pancreas (B), brain (C), kidney (D) and heart (E)
were all normalized to total lean mass, which was previously collected by QMR. After
normalization to lean mass, organ weights were not significantly different in any of the
mice (n=4, *P<0.05).
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Figure 3.8 Gonadal fat pad cells appear smaller in Tgfα null mice
Gonadal fat pads taken from female feed study mice were fixed, paraffin embedded and
stained with Hematoxylin and Eosin (H&E). The Tgfa null mice on both the LF and HF
diet appear to have smaller gonadal adipocytes than their control littermates.
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3.5

Gait analysis did not show any changes indicative of osteoarthritis

development due to diet-induced obesity
Changes in gait patterns are often assessed when studying individuals with OA. It
has been thought that obesity may affect biomechanical loading and contribute to changes
in gait patterns, which could lead to the development of OA (Griffin and Guilak 2005;
Harding, Hubley-Kozey et al. 2012). To examine if obese mice had altered gait patterns
and if these patterns were indicative of OA development, the Noldus CatWalk system
was used. Gait analysis showed that control mice on the HF diet shifted their weight to
their front paws significantly more than Tgfa null mice (Figure 3.9A). This was found by
determining the ratio of the front paw intensity over the hind paw intensity, through the
CatWalk 7.1 software. The paw intensity ratio was not significantly different between
the genotypes of mice on the LF diet, nor was it different between either control or Tgfa
null mice, after comparing between the diets (Figure 3.9A).
Two other gait parameters, stride length and swing speed, were analyzed for front
and hind paws individually. There were no significant differences observed in front or
hind limb stride length between genotypes of the mice, on either diet (Figure 3.9B,C).
The control mice on the HF diet had significantly shorter front and hind stride lengths
compared to control mice on the LF diet (Figure 3.9B,C). However there were no
significant differences in front and hind stride lengths of the Tgfa null mice, after
comparing between diets (Figure 3.9B,C). Control mice on the LF diet had a significantly
faster swing speed than their Tgfa null littermates and control mice on the HF diet, but
this significance was only found in the front limbs (Figure 3.9D). Front paw swing speed
was not found to be significantly difference in mice on the HF, after comparing between
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Figure 3.9 Changes in gait patterns are not indicative of obesity-induced OA
A CatWalk apparatus was used to capture paw intensity (A), front (B) and hind (C) limb
stride length and front (D) and hind (E) limb swing speed of female feed study mice, and
the data was analyzed using CatWalk 7.1 software (Noldus, VA, USA). The control mice
on the HF diet had a higher paw intensity ratio (front/hind) than Tgfa null mice. The
control mice on the LF diet had longer stride lengths in both their front and hind paws,
compared to control mice on the HF diet. The front limb swing speed of control mice on
the LF diet was significantly faster than Tgfa null mice on the same diet, and control mice
on the HF diet (n=4, *P<0.05).
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genotypes (Figure 3.9D). There were also no differences found in the front paw swing
speed of the Tgfa null mice, after comparing between diets (Figure 3.9D). Lastly, there
was no significant difference found in the swing speed of the hind paws (Figure 3.9E)

3.6

Diet-induced obesity is not sufficient to cause development of osteoarthritis in

Tgfa null or wild type mice
The diet used in this study has been shown to induce OA in the knees of female
C57BL/6J mice (Griffin, Fermor et al. 2010). Histological analysis using Safranin-O
staining was performed to determine the level of OA progression in the mouse knee
joints, and if any OA progression could be associated with diet-induced obesity.
Representative Safranin-O stained frontal knee sections of each of the genotypes, on
either diet, showed slight proteoglycan loss but overall healthy articular cartilage (Figure
3.10).
After staining we used a modified OARSI scoring system to obtain a semiquantitative score for the assessment of OA histopathology in the mouse (Glasson,
Chambers et al. 2010). No severe development of OA was found, as the total knee
OARSI scores were on average less than a score of 1, which indicated minimum
proteoglycan loss and small fibrillations, but no cartilage loss (Figure 3.11). There was no
significant difference in OARSI scores between genotypes of the mice, on either diet, nor
were there any differences observed in OARSI scores in Tgfa null or wild type mice, after
comparing between diets (Figure 3.11). This indicated the HF diet was not sufficient to
induce obesity in our lab, as I would have expected to observe significantly more
damage, and higher OARSI scores, at least in the control mice on the HF diet. The
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Figure 3.10 The high fat diet was not sufficient to induce OA
Frontally embedded knee sections stained with Safranin-O are representative of the
overall OARSI scores seen in the control and Tgfa null mice on the LF and HF diets. The
articular cartilage appears healthy in all animals, in all four quadrants of the knee. There
is no sign of cartilage damage in the mice on the HF diet that would indicate obesityinduced OA.
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Figure 3.11 Total knee OARSI scores do not indicate any obesity-induced OA
The overall score of the knees were collected using an OARSI grading system that is
designed to determine a semi-quantitative score for the histopathological assessment of
OA. Grading of frontally embedded Safranin-O stained knee sections of all the female
feed study mice revealed no differences between any of the mice, and no indication of
obesity-induced OA (n=4, *P<0.05).
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damage observed only suggested early signs of spontaneous OA development.
Furthermore, since the HF diet was insufficient to induce OA, I could not determine
whether a lack of Tgfa conferred protective effects against the development of obesity
associated OA.
To ensure taking the total knee OARSI score did not mask any damage in the four
knee quadrants, analysis of the medial femoral condyle (MFC), medial tibial plateau
(MTP), lateral femoral condyle (LFC) and lateral tibial plateau (LTP) was done
individually. There were no significant differences in the individual OARSI scores of the
MFC, MTP, LFC or LTP between genotypes of the mice, on either diet (Figure 3.12AD). There was also no significant difference observed in the OARSI scores of the 4 knee
quadrants in either the Tgfa null or wild type mice, after comparing between diets (Figure
3.12A-D). Analysis of the OARSI scores in the individual knee quadrants confirmed this
particular HF diet was not sufficient to induce OA development under the conditions used
by our lab.
The most damage observed in any of the knee samples consisted of small
fibrillations at the superficial layer, Safranin-O staining loss and slight superficial layer
erosion (Figure 3.13). This damage was not representative of the overall OARSI scores
and would only indicate very early signs of OA progression. No clefts extending into the
mid-zone of the articular cartilage or other signs of later stage OA were observed in any
of the samples.
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Figure 3.12 OARSI scores of the four knee quadrants do not indicate any obesityinduced OA
After OARSI scores were assessed for the whole knee, individual scores were obtained
for the MFC (A), MTP (B), LFC (C) and LTP (D) to ensure any damage in the individual
knee quadrants was not being masked. All four quadrants had individual OARSI scores
below 1, again indicating there was no obesity-induced OA found in any of these mice
(n=4, *P<0.05)
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Figure 3.13 Control mouse on the HF diet has the highest OARSI score
Safranin-O stained, frontally embedded knee section of one control mouse on the HF diet
represents the highest OARSI score seen in any of the mice. Arrows indicate
proteoglycan loss and small fibrillations on the articular surface.
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3.7

Male and female C57BL/6J body weight declines at 24 and 21 months of age,

respectively
To understand the occurrence of spontaneous OA in C57BL/6J mice, it is
important to note physiological changes accompanying aging that could increase the risk
of developing OA. Obesity has long been known as a risk factor for developing OA, and
formed the basis of our Tgfa feed study trial. We wanted to examine the weight
distributions in both male and female wild type mice to determine if there were any
significant changes with age, and if these changes were associated with an increase in
spontaneous OA development. The weight of male mice peaked between 15 and 21
months of age and declined at 24 months. Male wild type mice at 15, 18 and 21 months
of age weighed significantly more than 3 month-old controls (Figure 3.14A). Male mice
at 12 and 24 months of age did not weigh significantly more than 3 month-old controls
(Figure 3.14A). Female wild type mice at 18 months of age weighed significantly more
than 3 month-old controls (Figure 3.14B). Female mice at 12, 15 and 21 months of age
showed no significant differences in weight, after being compared to 3 month-old
controls (Figure 3.14B). Female mice appeared to decline in weight at a younger age,
although the weight distribution of 24 month-old female mice would be needed to
confirm this decline.

3.8

Changes in metabolic plasma markers upon aging
Blood glucose and circulating cholesterol and triglyceride levels taken from

plasma were measured to investigate if any changes occurred with age, and if these
changes were associated with OA development. Hyperglycemia, hypercholesterolemia
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Figure 3.14 Weights of male and female C57BL/6J decline at 24 and 21 months,
respectively
Male and female wild type mice were weighed prior to sacrifice at their respective time
points. Male mice aged 15, 18 and 21 months weighed significantly more than 3 monthold controls (A). However, male mice 12 and 24 months of age did not weigh
significantly more than 3 month-old controls. Female mice 21 months of age weighed
significantly more than 3 month-old controls (B). (n=5-9 (A), n=3 (B), *P<0.05).

61

Figure 3.15 Changes in metabolic plasma markers during aging
Blood glucose (A,B) levels of male and female C57BL/6J mice were taken immediately
after cardiac puncture with a Bayer Contour® meter and strips. Plasma was collected and
sent to the Phenotyping Laboratory at the Robarts Research Institute to analyze
circulating levels of cholesterol (C,D) and triglycerides (E,F). Circulating triglyceride
levels were only significantly lower in 21 month old males, when compared to 3 month
old controls, no other significant differences were observed (n=3-9 (A,C,E), n=3 (B,D,F),
*P<0.05).
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and hypertriglyceridemia have all been associated with OA development (Hart, Doyle et
al. 1995; Sturmer, Sun et al. 1998). After endpoint cardiac puncture, blood glucose levels
of male and female wild type mice were taken immediately. There were no significant
differences in blood glucose levels at any age, in either male or female mice (Figure
3.15A,B). Plasma collected from cardiac puncture was analyzed for circulating levels of
cholesterol and triglycerides. Cholesterol levels were not significantly different at any
age, in either male or female mice (Figure 3.15C,D). Significantly higher circulating
triglyceride levels were observed in 21 month-old male mice compared to 3 month-old
control mice, but were not significantly different at any other age (Figure 3.15E). In
female mice, triglyceride levels were not significantly different at any age (Figure 3.15F).

3.9

Gait analysis of male C57BL/6J mice revealed a decline in stride length and

swing speed with age
Several studies have been done to document the rates of spontaneous OA in aging
wild type mice, although none have used gait analysis to assess OA development in aging
C57BL/6J male and female mice. Utilizing the Noldus CatWalk and CatWalk 7.1
software, differences in gait patterns that could be indicative of OA development were
analyzed. The paw intensity ratio was used to determine whether mice were shifting their
weight to their front paws, which could be an indicator of hind limb OA development.
However there were no significant differences found in the paw intensity ratio of male
mice, at any age (Figure 3.16A).
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Figure 3.16 Male C57BL/6J mice have decreased stride length and front limb swing
speed with age
Gait analysis utilized the CatWalk system (Noldus Information Technology, VA) at the
Robarts Research Institute Behavioral Facility to detect any changes in paw intensity
front/hind limb ratio (A), front and hind limb stride length (B,C) and front and hind limb
swing speed (D, E). No significant changes were observed in the paw intensity ratio
(front/hind). Male mice had significantly reduced stride length (mm) in their front and
hind limbs at 18, 21 and 24 months of age when compared to 3 month-old controls.
Swing speed (m/s) was significantly slower in front limbs 24 month-old males, but no
differences were found in the hind limbs (n=5-9, *P<0.05).
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The other gait parameters analyzed were stride length and swing speed. Male wild
type mice at 18, 21 and 24 months of age had a significantly reduced stride length
compared to 3 month-old controls, in both their front and hind limbs (Figure 3.16B,C).
Male mice 12 and 15 months of age did not have any significantly different stride
lengths, after being compared to 3 month-old controls (Figure 3.16B,C). The swing speed
in 24 month-old male mice was significantly slower than in 3 month-old controls, but in
the front limbs only (Figure 3.16D). Swing speed in male wild type mice was not
significantly different at any other age in the front limbs, nor was any significance found
in the swing speed of the hind limbs (Figure 3.16E).

3.10

Gait analysis of female C57BL/6J mice showed no significant changes
The same gait parameters, paw intensity ratio, stride length and swing speed, were

analyzed in female C57BL/6J mice. Unlike the male mice, females showed no significant
differences in any of the analyzed gait parameters (Figure 3.17A-E).

3.11

Aging male C57BL/6J mice show significantly more osteoarthritis
Gait analysis alone was not sufficient to determine any physiological changes that

would confirm the presence of OA. The knee joints of male and female wild type mice
were harvested, sectioned and stained with Safranin-O staining. Representative SafraninO stained knee sections of 18 and 24 month-old mice showed the most commonly
observed damage, which was proteoglycan loss, fibrillation and slight cartilage erosion
(Figure 3.18). After staining the OARSI scoring system was used to determine a semiquantitative score for OA histopathology in the mouse knee
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Figure 3.17 No significant changes in the gait patterns of female C57BL/6J mice
Gait analysis utilized the CatWalk system (Noldus Information Technology, VA) at the
Robarts Research Institute Behavioral Facility to detect any changes in paw intensity
front/hind limb ratio (A), front and hind limb stride length (B,C) and front and hind limb
swing speed (D, E) of female mice. No significant differences were observed in any of
the gait parameters of female C57BL/6J mice (n=3, *P<0.05).
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Figure 3.18 Male 18 and 24 month-old C57BL/6J mice have more histological
damage
Safranin-O stained frontal knee sections of 3 (A), 18 (B) and 24 (C) month-old mice are
representative of overall total OARSI scores. Arrows indicate proteoglycan loss,
fibrillations and slight cartilage erosion.
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Figure 3.19 Male C57BL/6J mice at 18 and 24 months of age have higher total knee
OARSI scores
An OARSI scoring system was used to assign a semi-quantitative score for OA
histopathology in the mouse knee. Total knee OARSI scores were higher in 18 and 24
month-old male mice, compared to 3 month-old controls (n=5-9, *P<0.05).
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(Glasson, Chambers et al. 2010). The total score of the knee was graded first and it was
found that 18 and 24 month-old male mice had significantly higher OARSI scores than 3
month-old controls (Figure 3.19). There were no significant differences in total knee
OARSI scores found in 12, 15 or 21 month-old mice (Figure 3.19).
Next the MFC, MTP, LFC and LTP, were analyzed next to observe any individual
differences in knee quadrants of male C57BL/6J mice. Representative Safranin-O stained
knee sections revealed the damage observed in the MTP, LTP and LFC of 24 month-old
mice compared to 3 month old controls (Figure 3.20). The MTP, LTP and LFC, but not
the MFC of 24 month-old mice were found to have significantly higher OARSI scores,
compared to 3 month-old male mice (Figure 3.21A-D). The OARSI scores were not
significantly different in any of the quadrants in 12, 15, 18 or 21 months, after being
compared to the 3 month-old control mice (Figure 3.21A-D).
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Figure 3.20 Male 24 month-old C57BL/6J mice have more histological damage in
their MTP, LFC and LTP but not their MFC
Safranin-O stained sections of the individual knee quadrants, MFC, MTP, LFC and LTP
of 3 and 24 month-old male C57BL/6J mice. There is significantly more damage in the
MTP, LFC and LTP, but not the MFC of 24 month-old mice compared to 3 month-old
controls. Arrows indicate proteoglycan loss, fibrillations and cartilage erosion.
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Figure 3.21 Male C57BL/6J mice at 24 months of age have higher MTP, LFC and
LTP OARSI scores
An OARSI scoring system was used to assign a semi-quantitative score for OA
histopathology in each of the four quadrants of the mouse knee. The OARSI scores of the
MFC were not significantly different at any age, while the MTP, LFC and LTP scores
were significantly higher in 24 month-old males compared to 3 month-old controls (n=59, *P<0.05).
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3.12

Female C57BL/6J mice did not show any age associated spontaneous

osteoarthritis development
To assess the rate of spontaneous OA in female wild type mice, the same
Safranin-O and OARSI grading protocols as for the wild type males were used.
Representative Safranin-O stained frontal knee sections showed low to no damage in all
ages of female C57BL/6J mice, and overall healthy articular cartilage (Figure 3.22).
There were no significant differences in total knee OARSI scores found in female wild
type mice, at any age (Figure 3.23). To be sure the total knee scores were not masking
any differences in the 4 knee quadrants, individual scores of the MFC, MTP, LFC and
LTP were assessed. There were no significant differences in MFC, MTP, LFC or LTP
OARSI scores in female mice, at any age (Figure 3.24A-D).
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Figure 3.22 Female C57BL/6J mice did not show histological signs of OA
Safranin-O stained frontal knee sections of 3 (A), 12 (B), 15 (C), 18 (D) and 21 (E)
month-old mice are representative of overall total OARSI scores. Female mice do not
show any significant signs of spontaneous OA development at any age.
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Figure 3.23 Female C57BL/6J mice did not develop OA
An OARSI scoring system was used to assign a semi-quantitative score for OA
histopathology in the mouse knee. No significant differences were found between any of
the female mice, and average total knee OARSI scores were less than one, indicating no
significant OA development in the female mice (n=3, *P<0.05).
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Figure 3.24 Female C57BL/6J mice have no difference in individual MFC, MTP,
LFC or LTP OARSI scores
An OARSI scoring system was used to assign a semi-quantitative score for OA
histopathology in each of the four quadrants of the mouse knee. No significant
differences in OARSI scores were observed in the MFC (A), MTP (B), LFC (C) or LTP
(D) of female mice at any age (n=3, *P<0.05).
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4.0 DISCUSSION
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4.1

Overview
The overall objective of my thesis was to investigate two different models of the

two most common risk factors for OA, obesity and aging, to uncover the roles of these
risk factors in the pathogenesis of OA. The first part of my thesis was to determine if the
lack of Tgfa conferred protective effects against obesity-induced OA. The high fat (HF)
diet used in this study, previously shown to cause OA development in wild type mice,
was not sufficient to induce OA in control or Tgfa null mice in our hands. The Tgfa null
mice, unexpectedly, gained less weight than controls on the HF diet. Since the HF diet
was unable to induce OA, and the Tgfa null mice did not gain as much weight as the
controls, I could not determine if Tgfa deficiency protects against obesity-induced OA.
However, the reduction in weight, fat mass, cholesterol levels and liver mass may suggest
a novel role for the Tgfa gene in metabolism.
The second part of my thesis was to determine the progression of spontaneous OA
in aging male and female C57BL/6J mice, utilizing updated staining and grading
techniques and for the first time analysis of gait pattern changes. While there was an
increase in spontaneous OA in male mice with aging, especially in the 24 month-old
mice, it was not as severe as originally anticipated. Gait analysis demonstrated
significantly shorter stride lengths in 18, 21 and 24 month-old mice, which potentially
indicates the presence OA. However, 21 month-old mice did not have significantly
different OARSI score from 3 month-old control mice, suggesting that gait analysis alone
is not a definitive predictor of OA. Conversely, female mice showed no significantly
different gait pattern changes or OARSI scores, suggesting that female C57BL/6J are less
susceptible to developing spontaneous OA.
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I unexpectedly discovered in the first part of my thesis that Tgfa null mice
weighed significantly less than control mice on the HF diet, which prompted further
experiments to determine the cause of this phenomenon. Analysis with QMR revealed
that Tgfa null mice weighed less due to a reduction in total fat mass, as lean mass was not
significantly different. These results were surprising, as one study found that mice
overexpressing Tgfa were significantly smaller, mostly due to a reduction of
approximately 50 percent of their total body fat when compared to control littermates
(Luetteke, Lee et al. 1993). Although the Tgfa null mice were only significantly smaller
on the HF diet, the same trend was observed in Tgfa null mice on the LF diet. I would
predict that additional trials would produce significant results in regards to the total
weight and fat mass differences observed in the Tgfa null mice on the LF diet.
Another surprising result from my study was that the liver of Tgfa null mice
weighed significantly less than that of control mice, on the both the LF and HF diets.
After normalization to body weight, I found that the livers in Tgfa null mice on the LF
diet were still significantly smaller than controls. One potential explanation for this
difference in liver size could be due to TGFα involvement in liver cell (hepatocyte)
proliferation. During liver regeneration the levels of TGFα mRNA significantly increased
in CD albino rats, and the overexpression of Tgfa in mice caused enlargement of the liver,
likely due to increased hepatocyte proliferation (Mead and Fausto 1989; Webber, Wu et
al. 1994). Thus, the reduction in liver size in my Tgfa null mice on normal diet could be
due to decreased hepatocyte proliferation. This result from my study therefore provides
further evidence for a role for TGFα in liver cell proliferation, although further
experiments would be needed to establish this. Although liver weight was not
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significantly lower in Tgfa null mice on the HF diet after normalization to body weight,
there was still a trend towards smaller liver size. Another explanation for a reduction in
liver size could be due to decreased hepatic steatosis. Hepatic steatosis is an accumulation
of fat, typically triglycerides, in the liver that can occur due to obesity (Browning and
Horton 2004). Since the Tgfa null mice did not gain as much weight, this trend in
decreased liver size could be explained by reduced lipid accumulation in the liver.
Lower levels of circulating cholesterol were found only in Tgfa null mice on the
HF diet, when compared to control littermates. The differences in cholesterol levels
between the genotypes were expected, as the Tgfa null mice did not become obese, and
obesity is associated with higher levels of cholesterol (Mokdad, Ford et al. 2003).
Interestingly, I found no difference in circulating triglyceride or blood glucose levels in
any of the mice. This is difficult to explain since elevated blood triglycerides and glucose
levels have been long associated with obesity (Grundy 2004).
The lack of OA development in the mice in this study was surprising, considering
that the same diet has been shown to induce OA in female wild type mice of the same
C57BL/6J background as mice used in my study (Griffin, Fermor et al. 2010). Typically
obesity is thought to influence OA through both biomechanical and metabolic effects.
Control mice on the HF diet did not develop obesity-induced OA, but they did become
quite obese, with some mice weighing over 70 grams. As the mice become more obese,
their abdomen also became larger and occasionally touched the bottom of the cage. This
weight gain could act as a relief to the load bearing stress that would usually be taken on
by the joints. As mice are quadrupeds and humans are bipeds, the load bearing effect in
joints of obese mice may not be the same seen in humans. However this does not account
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for the inconsistency between my work and previous reports that have shown strong
association between a HF diet and the development of OA (Silberberg and Silberberg
1950; Griffin and Guilak 2008; Griffin, Fermor et al. 2010).
Mice that are lacking leptin, an adipokine known to regulate chondrocyte
differentiation, become extremely obese but do not develop OA (Kishida, Hirao et al.
2005; Griffin, Huebner et al. 2009). These systemic effects could also explain why the
mice in my study did not develop OA, since weight gain alone may not be sufficient to
induce OA. It has been shown that mice overexpressing Tgfa on a high fat diet had
significantly increased levels of leptin (Cleary, Grande et al. 2004; Dogan, Hu et al.
2007). Perhaps there is interaction between TGFα and leptin, and loss of Tgfa may cause
a decrease in circulating leptin, which could provide protective effects against obesityinduced OA as seen in the leptin-deficient mouse study (Griffin, Huebner et al. 2009).
Measurements of leptin levels in our mice would be an important task for future
experiments.
Aged male and female C57BL/6J mice both reached a peak in weight gain before
exhibiting a decline at 24 months. This observation is not surprising as many elderly
people also exhibit age-related weight decline (Alibhai, Greenwood et al. 2005). One
study in mice found that weight decline could also be a predictor of spontaneous death, as
they observed a significant decline in the weight of C57BL/6J mice approximately ten
weeks prior to death (Trammell, Cox et al. 2012). This would be useful to observe in
future long-term studies to avoid loosing animals unexpectedly.
The blood glucose and circulating cholesterol and triglyceride levels in male and
female C57BL/6J mice remained mostly unchanged with age, except for elevated
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triglyceride levels in 21 month-old male mice. One study found that cholesterol levels in
aging male and female C57BL/6J were not significantly different when compared to
younger mice, which is similar to the results seen in the mice in my study (Weibust
1973). Another study observed lower triglyceride levels and development of glucose
intolerance in aging C57BL/6J mice, when compared to younger mice of the same strain
(Houtkooper, Argmann et al. 2011). In contrast, triglyceride levels went up in 21 monthold mice in my study, although this was only in males and the trend did not continue with
further aging. Since the mice in my study showed no particular pattern in regards to
triglyceride levels, this result is not likely indicative of any significant age related
changes in triglyceride metabolism.
The mice used in my study were only tested for end point whole blood glucose
levels; whereas most studies test plasma glucose levels to test for changes that could
indicate altered glucose tolerance (Ayala, Samuel et al. 2010). Glucose intolerance has
been documented in younger C57BL/6J mice being fed a standard diet, and in aging
C57BL/6J mice (Kaku, Fiedorek et al. 1988; Houtkooper, Argmann et al. 2011). With the
results from my study I can only determine if fasting blood glucose levels are within the
normal range, at the time of sacrifice. Normal ranges for inbred mouse strains, such as the
C57BL/6J mice used in my study, are between 140 mg/dl and 220 mg/dl (8-12 mmol/l)
(Clee and Attie 2007). The average fasting blood glucose levels were around 10 mmol/l
at each age interval studied in my experiments, in both female and male mice. In male
mice, there were outliers around 15 mmol/l, but they were not indicative of any agerelated trends. Overall the mice in my study appear to have relatively normal fasting
blood glucose levels, and further experiments would need to be done to determine if my
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mice also exhibit glucose intolerance with age as seen in previous studies (Kaku,
Fiedorek et al. 1988; Houtkooper, Argmann et al. 2011).
While male C57BL/6J mice show more development of spontaneous OA with
age, the most significant OA was found in 24 month-old mice, when comparing them to 3
month-old controls. Although development of OA was observed, it was not as severe as
we expected. One study in aging C57BL/6J mice saw an increase of approximately 80
percent in the incidence of OA by just 16 months of age, with the severity of OA also
increasing with age (Yamamoto, Shishido et al. 2005). While it is difficult to identify
exactly why the mice in my study did not develop more frequent and severe OA with age,
activity level could provide one explanation. Moderate running training in C57BL/6 mice
accelerated the development of OA in active mice compared to non running-trained
controls (Lapvetelainen, Nevalainen et al. 1995).
Reduced stride length in 18, 21 and 24 month old male mice was observed in their
front and hind limbs. This result is similar to the reduced knee extensor moments seen in
patients with OA when compared to healthy individuals (Kaufman, Hughes et al. 2001).
Although, due to other changes that occur with age in mice, such as muscle weakness,
these gait results cannot definitively conclude if a reduction in stride length is associated
with OA (Phillips, Bruce et al. 1991). In addition, since 21 month-old male did not have
significant development of OA as demonstrated by overall or individual knee quadrant
OARSI scores, this result does not support the association between reduced stride length
and OA development.
Female C57BL/6J mice did not develop OA, even at 21 months of age. Several
studies have shown that female mice are less susceptible to OA development in other
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mouse models (Rosner, Goldberg et al. 1986; de Hooge, van de Loo et al. 2005). A
surgically induced model of OA involving the destabilization of the medial meniscus
(DMM) in mice demonstrated that males had higher severity of OA compared to females
that had the same surgery (Ma, Blanchet et al. 2007). In order to further study the effects
of aging in female C57BL/6J mice, later time points past 21 month should be observed.

4.2

Expected Results
While this study had several unexpected results, the reduced weight gain in Tgfa

null was particularly surprising and I found myself unable to definitively determine the
role of TGFα in obesity-associated OA. Originally I hypothesized that a lack of TGFα
would confer protective effects against obesity-induced OA, as loss of TGFα has been
found by a previously lab member to protect against post-traumatic OA (Appleton et al.,
submitted). As per my hypothesis, I expected to see significantly higher OARSI scores
indicating more severe articular cartilage damage and ECM loss in control mice, with the
highest severity in control mice on the HF diet, when compared to Tgfa null mice. I
would have also expected to see elevated blood glucose and circulating cholesterol and
triglycerides in the control mice on the HF diet, as these metabolic factors are involved in
both obesity and OA (Hart, Doyle et al. 1995; Sturmer, Sun et al. 1998).
Had my study demonstrated these expected results, I would next need to
determine if the protection against obesity-induced OA observed in Tgfa null mice was
due to metabolic changes, or if the effect was cartilage-specific. To investigate cartilage
specific effects, a conditional Tgfafl/fl mouse would need to be generated. The Tgfafl/fl
mouse would be crossed with a mouse that expresses cartilage-specific Cre recombinase
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(Col2Cre). The Col2Cre mice are already available in our lab, and have been used in
several published projects (Wang, Woods et al. 2007; Solomon, Li et al. 2009; Gillespie,
Ulici et al. 2011). The newly generated Col2Cre- Tgfafl/fl mice would be subjected to the
same protocols to determine if the cartilage-specific knockout of Tgfa is protective
against obesity-induced OA.
The severity of spontaneous OA development in aging C57BL/6J mice was not as
high as expected. Originally I hypothesized that male and female C57BL/6J would show
a higher incidence of spontaneous OA with aging, and that the most severe spontaneous
OA would be in the oldest mice. If my study had demonstrated these results, I would next
need to investigate the potential cause behind the increased rate and severity of
spontaneous OA associated with aging. I would first perform an immunohistochemistry
(IHC) for OA markers such as MMP13 and collagen II breakdown fragments. I would
expect the levels of these markers to be higher in the oldest and most severely damaged
tissues. Additionally, if results had been as expected, this study would have also
investigated the role of TGFα in aging. To begin, levels of TGFα and phosphorylatedEGFR would have been assessed with IHC; we would expect to find increased levels of
both TGFα and phosphorylated-EGFR. I would then examine aging-associated OA in
Tgfa null mice to determine if a lack Tgfa provides any protective effects.

4.3

Contributions to the Fields of Osteoarthritis and Transforming Growth

Factor Alpha
OA is actively studied by many researchers, yet very little is known about the
exact pathogenesis of the disease. I originally wanted to discover a role for TGFα in
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obesity-associated OA, and instead found that a previously successful protocol for dietinduced OA did not produce the same effects in my study. This demonstrates the
variability of OA development, even within the same protocol, indicating the necessity to
use multiple models to study the effects of OA. This study also demonstrated the need for
consistency and descriptiveness in protocols for OA models. Activity level, number of
mice per cage and even bedding can potentially affect the outcome of an otherwise
identical experiment.
This study has further contributed to the field of OA by demonstrating the
differences between male and female mice, in regards to age-related spontaneous OA
development. While it has been documented that female mice develop less OA than male
mice in post-traumatic models, to date none of these studies looked at the rate of
spontaneous OA solely due to aging in C57BL/6J mice (de Hooge, van de Loo et al.
2005; Ma, Blanchet et al. 2007). This study has further demonstrated that C57BL/6J
females are less susceptible to developing age-related spontaneous OA than males. Gait
analysis has provided updated functional analysis of aging C57BL/6J male and female
mice. Gait analysis coupled with a modern OARSI grading system has demonstrated that
male mice, especially mice at 24 months of age, have increased instance of spontaneous
OA whereas females do not show the same pattern. This study has provided a sufficient
amount of evidence, which can be used as an updated report on the rate of spontaneous
OA in aging male and female C57BL/6J, a strain that is commonly used in OA research.
While my study was unable to determine if TGFα deficiency conferred protective
effects to obesity-induced OA, it has demonstrated a potential role for TGFα in
metabolism. For the first time my study has observed a resistance to weight gain in Tgfa
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null mice when fed a HF diet. The Tgfa null mice also have reduced total body fat and
lower levels of circulating cholesterol on the HF diet, and smaller livers than control mice
on the LF diet. Since the liver regulates cholesterol biosynthesis and TGFα is involved in
liver cell proliferation, the reduction in circulating cholesterol and liver size the mice in
my study are potentially caused directly by a lack of Tgfa (Mead and Fausto 1989).
Gait analysis revealed that the front and hind limb stride length, and front limb
swing speed of control mice on the LF diet were significantly higher than control mice on
the HF diet. While other studies have looked at gait in obesity-induced OA mouse
models, to date none have looked at the effect of obesity in the gait, CatWalk, system
(Griffin, Fermor et al. 2010; Little and Zaki 2012). The Tgfa null mice on the HF did not
have the same reduced stride length or front paw swing speed as the control mice, when
compared to the control mice on the LF diet. This demonstrates that gait changes may be
due to obesity and Tgfa null may be protected from these changes, since they do not
become as obese as control mice on the HF diet. This study has demonstrated a necessity
for continued research in order to further investigate and understand the role of TGFα in
metabolism.

4.4

Limitations
This study had many unexpected results, and while these results highlighted the

potential for other areas of research, they also demonstrated a number of limitations. The
original aim of the feed study portion of my project was to generate eleven trials, eight
female and three male. While there are no known breeding difficulties in the Tgfa-/+ mice,
I had frequently observed litters under five pups, making it difficult to obtain the correct
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genotypes for a trial (Mann, Fowler et al. 1993). Difficultly with breeding persisted and
resulted in the collection of only six female and two male trials. These trials all survived
without issues until the six month on the diet, at which point several mice did succumb to
injuries from ulcerative dermatitis, a condition that is known to affect the C57BL/6J
background (Hampton, Hish et al. 2012). Our lab has also theorized that the beta-chip
bedding these mice were housed in was exacerbating the skin condition. However,
dermatitis also affected the survival of male and female C57BL/6J mice in the aging
study, and they were not housed in beta-chip bedding. Unfortunately there was no way to
overcome these limitations and only 4 complete female and 1 complete male trial reached
the 54 week time point.
The diet used in my study had been previously shown to induce OA in female
wild type mice, and was intended to induce OA in my feed study mice to investigate if a
lack of Tgfa was protective against obesity-induced OA (Griffin, Fermor et al. 2010).
Surprisingly, I found no OA development in any of the mice, including the controls on
the HF diet. Although diet-induced obesity was sufficient to cause OA development in
mice in the previous study, there could have been other underlying factors that aided in
OA development. This study was limited to the diet and housing described by the
protocol, as we did not know if the mice used in the previous study had higher activity
levels (e.g. because of larger cages or access to exercise equipment such as wheels),
which would also affect the development of OA.
In the aging male and female C57BL/6J mice, many spontaneous deaths occurred
either due to the aforementioned ulcerative dermatitis or from unknown causes. This was
a limitation as many of the mice died before developing OA. Furthermore, due to the
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length of this study once a mouse died, it was difficult to start over as some of these mice
needed to live up to two years.
Lastly there were also limitations in the interpretation of the gait analysis data.
While changes in stride length were seen in older male mice, I cannot confirm whether
this was due to OA development. Muscles tend to become weaker with age, so it is
difficult to distinguish if changes in gait are due to OA or weakening of the musculature
(Phillips, Bruce et al. 1991). Gait changes were initially expected to be due to the pain
associated with OA, but since mice are prey in nature they tend to hide signs of moderate
pain and weakness (Arras 2007). This would make it difficult to even detect gait changes
associated with OA pain until the diseased had progressed to a much later, and more
severe stage. Despite these limitations I was still adequately able to investigate both of
the hypotheses in my study.

4.5

Future Directions
This study has demonstrated numerous findings that are the basis for further

research in the area of OA and TGFα in metabolism. Even though the female feed study
mice in this study did not develop OA, it would be interesting to repeat the same study in
male mice as in they are more susceptible to OA in other research models, such as my
aging studies or models of surgically induced OA (Ma, Blanchet et al. 2007). Generating
male trials may allow us to determine if a lack of Tgfa is protective against obesityinduced OA, which would further highlight the importance of TGFα as a therapeutic
target for OA.
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It would also be interesting to investigate if TGFα does play a role in metabolism.
Significant concentrations of TGFα were found in adipose fractions of epididymal
(gonadal fat) and perirenal (peripheral kidney fat) in male Sprague-Dawley rats
(Crandall, Gordon et al. 1992). Another study has demonstrated by Northern blot that
Tgfa mRNA was expressed in gonadal and renal adipose tissue of control and obese mice
(Luetteke, Lee et al. 1993). However the mice from this study were not fed a HF diet, and
were obese due to a homozygous recessive mutation (ob/ob) (Luetteke, Lee et al. 1993).
It would be worthwhile to investigate whether diet-induced obese wild type mice have
higher levels of TGFα mRNA in adipose tissue depots, or in other metabolic tissues,
compared to lean wild type mice. Furthermore, a luminex assay could be used to quantify
levels of leptin and other adipokines from plasma already collected during my study, to
determine if a lack of TGFα causes any significant changes to circulating levels of
adipokines. Future experiments could also determine if TGFα interacts with leptin, either
directly or indirectly, as leptin is expressed in adipocytes and plays a large role in the
controlling the body weight of mice (Zhang, Proenca et al. 1994; Maffei, Fei et al. 1995).
It would also be worthwhile to investigate the progression of spontaneous OA in
other joints such as the spine, ankle and elbow in the C57BL/6J mice, as they have
already been collected. In addition, we would need to extend the end collection time
points of female wild type mice to see if OA development occurs at ages past 21 months.

4.6

Conclusion
OA is a highly prevalent degenerative joint disease for which the exact

mechanisms of pathogenesis remain largely unknown. While many factors can lead to
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OA, aging and obesity are considered the two main risk factors. The two mouse models
used in this study have further demonstrated the complexity and variability of the
development of OA. Although the role of TGFα in obesity-associated OA was not clearly
determined, this study has highlighted TGFα as a potential regulator of body metabolism.
Results from aging C57BL/6J male and female mice have provided an updated report on
the rate of spontaneous OA due to aging, though utilization of several updated
techniques. Overall this study provided a stepping off point for several future experiments
that could contribute to the fields of OA and metabolic research.
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APPENDICIES
Appendix A: Animal Use Protocol
All animal experimentation was conducted in compliance with the animal use protocol (AUP)
2007-045 held by Dr. Frank Beier, principal investigator at the Schulich School
of Medicine and Dentistry and the department of Physiology and Pharmacology at the University of
Western Ontario in London, Ontario, Canada.

2007-045-06::5:
AUP Number: 2007-045-06
AUP Title: Regulation of Endochondral Bone Growth by Hormones
Yearly Renewal Date: 08/01/2012
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2010-268 has been approved, and will
be approved for one year following the above review date.
1. This AUP number must be indicated when ordering animals for this project.
2. Animals for other projects may not be ordered under this AUP number.
3. Purchases of animals other than through this system must be cleared through the ACVS office.
Health certificates will be required.
REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this protocol,
are familiar with the contents of this document.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety components
(biosafety, radiation safety, general laboratory safety) comply with institutional safety standards and
have received all necessary approvals. Please consult directly with your institutional safety officers.
Submitted by: Kinchlea, Will D
on behalf of the Animal Use Subcommittee
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